Strafford will be offering a webinar entitled "Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe and China" on January 31, 2018 from 1:00 to 2:30 pm (EST). Bryan C. Diner and Carla Mouta-Bellum of Finnegan Henderson Farabow Garrett & Dunner, Amy Feng of Wu Feng & Zhang, and Hazel Ford of Finnegan Europe will provide guidance to patent counsel on overcoming the challenges of obviousness in biologics patent claims in the U.S., Europe, and China; will examine the similarities and differences between claim types that have the best chance of success; and will discuss recent case law and key issues that arise. The webinar will review the following issues:
• What evidence should counsel provide to support its assertion of nonobviousness in biologics patents?
• How can counsel overcome the inconsistency in the EPO's treatment of biologics patents?
• How can patent counsel guide applicants during patent application drafting to reduce the likelihood of rejection?
The registration fee for the webcast is $297. Those interested in registering for the webinar, can do so here.